BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34814099)

  • 41. Neuropsychiatric manifestations in vascular cognitive impairment patients with and without dementia.
    Chiu PY; Liu CH; Tsai CH
    Acta Neurol Taiwan; 2007 Jun; 16(2):86-91. PubMed ID: 17685132
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia.
    Lavretsky H; Zheng L; Weiner MW; Mungas D; Reed B; Kramer JH; Jagust W; Chui H; Mack WJ
    Int J Geriatr Psychiatry; 2008 Oct; 23(10):1040-50. PubMed ID: 18412291
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of neurodegenerative types using different brain MRI analysis metrics in older adults with normal cognition, mild cognitive impairment, and Alzheimer's dementia.
    Choi M; Youn H; Kim D; Lee S; Suh S; Seong JK; Jeong HG; Han CE
    PLoS One; 2019; 14(8):e0220739. PubMed ID: 31369629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The balance between cognitive reserve and brain imaging biomarkers of cerebrovascular and Alzheimer's diseases.
    Murray AD; Staff RT; McNeil CJ; Salarirad S; Ahearn TS; Mustafa N; Whalley LJ
    Brain; 2011 Dec; 134(Pt 12):3687-96. PubMed ID: 22102649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apathy is a prominent neuropsychiatric feature of radiological white-matter changes in patients with dementia.
    Jonsson M; Edman A; Lind K; Rolstad S; Sjögren M; Wallin A
    Int J Geriatr Psychiatry; 2010 Jun; 25(6):588-95. PubMed ID: 19852002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frontotemporal dementia in Oman: cognitive behavioural profile and neuroimaging characteristics; a prospective hospital-based study.
    Shelley BP; Al-Khabouri J; Hussein SS; Raniga SB
    J Neurol Sci; 2007 Sep; 260(1-2):167-74. PubMed ID: 17544447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Midlife Insulin Resistance as a Predictor for Late-Life Cognitive Function and Cerebrovascular Lesions.
    Toppala S; Ekblad LL; Lötjönen J; Helin S; Hurme S; Johansson J; Jula A; Karrasch M; Koikkalainen J; Laine H; Parkkola R; Viitanen M; Rinne JO
    J Alzheimers Dis; 2019; 72(1):215-228. PubMed ID: 31561373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pattern of and risk factors for brain microbleeds in neurodegenerative dementia.
    Olazarán J; Ramos A; Boyano I; Alfayate E; Valentí M; Rábano A; Alvarez-Linera J
    Am J Alzheimers Dis Other Demen; 2014 May; 29(3):263-9. PubMed ID: 24408753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resistance, vulnerability and resilience: A review of the cognitive cerebellum in aging and neurodegenerative diseases.
    Liang KJ; Carlson ES
    Neurobiol Learn Mem; 2020 Apr; 170():106981. PubMed ID: 30630042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment Types.
    Camarda C; Pipia C; Azzarello D; Battaglini I; Romeo G; Chiodi M; Camarda R
    Curr Alzheimer Res; 2018; 15(7):679-690. PubMed ID: 29357798
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention.
    Scott TM; Bhadelia RA; Qiu WQ; Folstein MF; Rosenberg IH
    J Alzheimers Dis; 2018; 65(1):293-302. PubMed ID: 30040728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease.
    Woolley JD; Khan BK; Murthy NK; Miller BL; Rankin KP
    J Clin Psychiatry; 2011 Feb; 72(2):126-33. PubMed ID: 21382304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain structure and cerebrovascular risk in cognitively impaired patients: Shanghai Community Brain Health Initiative-pilot phase.
    He J; Iosif AM; Lee DY; Martinez O; Chu S; Carmichael O; Mortimer JA; Zhao Q; Ding D; Guo Q; Galasko D; Salmon DP; Dai Q; Wu Y; Petersen RC; Hong Z; Borenstein AR; DeCarli C
    Arch Neurol; 2010 Oct; 67(10):1231-7. PubMed ID: 20937951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions Between Acute Infarcts and Cerebrovascular Pathology Predict Poststroke Dementia.
    Yatawara C; Guevarra A; Ng KP; Chander R; Kandiah N
    Alzheimer Dis Assoc Disord; 2020; 34(3):206-211. PubMed ID: 32483018
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.
    Chai YL; Yeo HK; Wang J; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CL
    J Alzheimers Dis; 2016; 51(4):1111-8. PubMed ID: 26923016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Haemoglobin, magnetic resonance imaging markers and cognition: a subsample of population-based study.
    Tan B; Venketasubramanian N; Vrooman H; Cheng CY; Wong TY; Chen C; Hilal S
    Alzheimers Res Ther; 2018 Nov; 10(1):114. PubMed ID: 30400991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropsychiatric symptoms in severe dementia: Associations with specific cognitive domains the Cache County Dementia Progression Study.
    Rozum WJ; Cooley B; Vernon E; Matyi J; Tschanz JT
    Int J Geriatr Psychiatry; 2019 Jul; 34(7):1087-1094. PubMed ID: 30945374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia.
    Chai YL; Hilal S; Chong JPC; Ng YX; Liew OW; Xu X; Ikram MK; Venketasubramanian N; Richards AM; Lai MKP; Chen CP
    Medicine (Baltimore); 2016 Aug; 95(33):e4566. PubMed ID: 27537582
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Small Vessel Disease and Associations with Cerebrospinal Fluid Amyloid, Tau, and Neurodegeneration (ATN) Biomarkers and Cognition in Young Onset Dementia.
    Yatawara C; Ng KP; Cristine Guevarra A; Wong B; Yong T; Kandiah N
    J Alzheimers Dis; 2020; 77(3):1305-1314. PubMed ID: 32925034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum IL-8 is a marker of white-matter hyperintensities in patients with Alzheimer's disease.
    Zhu Y; Chai YL; Hilal S; Ikram MK; Venketasubramanian N; Wong BS; Chen CP; Lai MK
    Alzheimers Dement (Amst); 2017; 7():41-47. PubMed ID: 28239640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.